Pain
From the Journals
Cannabis falls short for chronic noncancer pain
Findings from a 4-year prospective cohort study are not a slam dunk against cannabis for chronic pain.
Conference Coverage
How to prescribe effectively for opioid use disorder
NEW ORLEANS –
Conference Coverage
New studies expand on Aimovig for migraine
SAN FRANCISCO – “It’s a very encouraging 1-year study for erenumab,” said Stewart J. Tepper, MD.
Conference Coverage
Opioid crisis brings bonanza for headache research
From the Journals
Nearly one-quarter of presurgery patients already using opioids
Surgical patients should be asked about their opioid use and pain history.
From the Journals
Assessing adverse events tied to outpatient opioid use in children
Conference Coverage
Migraine treatment insights offered for noninvasive vagus nerve stimulation
News from the FDA/CDC
Fentanyl analogs nearly double their overdose death toll
From 2016 to 2017, carfentanil-related deaths were up 98%.
Conference Coverage
Device impresses for chronic cluster headache attacks
Conference Coverage
OnabotulinumtoxinA crushes topiramate in chronic migraine PRO benefits
SAN FRANCISCO – Investigator asks: How can onabotulinumtoxinA possibly still be considered a third- or fourth-line therapy?
Conference Coverage
Study busts three migraine trigger myths